Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
The CC chemokine ligand 18 (CCL18) is produced by alveolar macrophages in patients with fibrosing lung disease and its concentration is increased in various fibrotic lung diseases. Furthermore CCL18 is elevated in several malignancies as it is produced by tumor associated macrophages. In this study...
Main Authors: | Eleni Gkika, Werner Vach, Sonja Adebahr, Tanja Schimek-Jasch, Anton Brenner, Thomas Baptist Brunner, Klaus Kaier, Antje Prasse, Joachim Müller-Quernheim, Anca-Ligia Grosu, Gernot Zissel, Ursula Nestle |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5619767?pdf=render |
Similar Items
-
Correction: Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)?
by: Eleni Gkika, et al.
Published: (2018-01-01) -
CC-chemokine ligand 18 induces epithelial to mesenchymal transition in lung cancer A549 cells and elevates the invasive potential.
by: Till Ploenes, et al.
Published: (2013-01-01) -
CCR2 and CXCR3 agonistic chemokines are differently expressed and regulated in human alveolar epithelial cells type II
by: Prasse Antje, et al.
Published: (2005-07-01) -
Serum level of CC-chemokine ligand 18 is increased in patients with non-small-cell lung cancer and correlates with survival time in adenocarcinomas.
by: Till Plönes, et al.
Published: (2012-01-01) -
Immunohistochemistry and Radiomic Features for Survival Prediction in Small Cell Lung Cancer
by: Eleni Gkika, et al.
Published: (2020-08-01)